XMRV was first linked to chronic fatigue syndrome – also known as myalgic encephalomyelitis (ME) – in a study published in October 2009, where blood samples from chronic fatigue syndrome patients were found to have traces of the virus. XMRV had also been identified previously in samples from certain prostate cancer patients.
The new study, published in ‘Retrovirology’, identifies the source of XMRV in chronic fatigue syndrome samples as being cells or mouse DNA rather than infection by XMRV. The research does not rule out a virus cause of chronic fatigue syndrome – it is simply not this virus.
The research team developed improved methods to detect XMRV against the genetic noise of other sequences and make recommendations for future study of virus causes of human disease.
“Our conclusion is quite simple: XMRV is not the cause of chronic fatigue syndrome,” says Professor Greg Towers, a Wellcome Trust Senior Research Fellow at University College London (UCL). “All our evidence shows that the sequences from the virus genome in cell culture have contaminated human chronic fatigue syndrome and prostate cancer samples.
“It is vital to understand that we are not saying chronic fatigue syndrome does not have a virus cause – we cannot answer that yet – but we know it is not this virus causing it.”
The team, from University College London, Wellcome Trust Sanger Institute and University of Oxford, showed clearly that the experimental design of previous studies would pick up sequences that resembled XMRV; however, in this improved study, they could prove that the signal was from contamination by a laboratory cell line or mouse DNA. The sequences from the contaminated cell line and chronic fatigue patient samples were extremely similar, contrary to the pattern of evolution expected during the infectious spread of a virus in a human population.
They also showed that the existing methods would indicate that one in fifty human cell lines they examined were infected with XMRV-related viruses: they showed that contamination of human tumour cells with XMRV-related viruses is common and that a principal prostate cancer line used is contaminated.
“When we compare viral genomes, we see signs of their history, of how far they have travelled in space or time,” says Dr Stéphane Hué, Post Doctoral Researcher at UCL. “We would expect the samples from patients from around the world, collected at different times, to be more diverse than the samples from within a cell line in a lab, where they are grown under standard conditions. During infection and transmission in people, our immune system would push XMRV into new genetic variants.
“Viral infection is a battle between the virus and the host and XMRV does not have the scars of a virus that transmits between people.”
Together the results demonstrate that XMRV does not cause chronic fatigue syndrome or prostate cancer in these cases. The team’s methods suggest ways to ensure that virus contamination does not confound the search for a cause of disease in future work.
The authors propose that more rigorous methods are used to prevent contamination of cell and DNA samples. They also suggest that consistent and considered standards are needed for identifying viruses and other organisms as cause of a disease.
“Increasingly, we are using DNA-based methods to accelerate our understanding of the role of pathogens in disease,” explains Professor Paul Kellam, Virus Genomics group leader from the Wellcome Trust Sanger Institute. “These will drive our understanding of infection, but we must ensure that we close the circle from identification to association and then causation.
The strongest lesson is that we must fully use robust guidelines and discriminatory methods to ascribe a cause to a disease.”
Image: the XMRV virus by AJC1 on Flickr.
Senior Media Officer
T +44 (0)20 7611 7329
Wellcome Trust Sanger Institute
Hinxton, Cambridge, CB10 1SA, UK
T +44 (0)1223 496 928
Notes for editors
Hué S, Gray ER, Gall A et al. (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology.
About the Wellcome Trust
Error – target node or document does not exist is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust’s breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.
About UCL (University College London)
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. UCL is among the world’s top universities, as reflected by performance in a range of international rankings and tables. Alumni include Marie Stopes, Jonathan Dimbleby, Lord Woolf, Alexander Graham Bell, and members of the band Coldplay. UCL currently has over 13,000 undergraduate and 9,000 postgraduate students. Its annual income is over £700 million.
About the Wellcome Trust Sanger Institute
The Wellcome Trust Sanger Institute, which receives the majority of its funding from the Wellcome Trust, was founded in 1992. The Institute is responsible for the completion of the sequence of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes. In October 2006, new funding was awarded by the Wellcome Trust to exploit the wealth of genome data now available to answer important questions about health and disease